Saturday, March 14, 2026
HomeSearch

Venture Capital - search results

Think Bioscience Raises $55M in Series A Funding

Think Bioscience ("Think Bio"), a biotechnology company focused on unlocking elusive drug targets, has raised $55M in an oversubscribed Series A. The round was...

Ethernovia Raises Over $90M in Series B Funding

Ethernovia, Inc., a semiconductor start-up building Ethernet-based, packet processor-centric networking solutions to support the real-time sensor, AI and control data demands of software-defined autonomy...

Transition Metal Solutions Raises $6M in Seed Funding

Transition Metal Solutions, a startup boosting copper production from existing mining operations and waste, today announced an oversubscribed $6 million seed round led by...

Quadric Raises $30M in Series C Funding

Quadric®, the inference engine that powers on-device AI chips, today announced an oversubscribed $30 million Series C funding round, bringing total capital raised to $72...

Vista AI Raises $29.5M in Series B Funding

Vista AI, Inc., the leader in automated MRI scanning software for hospitals and imaging centers, today announced the closing of $29.5 million in Series...

Juvena Therapeutics Raises $33.5M in Series B Funding

Juvena Therapeutics, a clinical-stage biotechnology company whose AI-enabled regenerative biologics are designed to restore tissue function, today announced its $33.5 million Series B. The...

Mirador Raises $250M in Series B Funding

Mirador Therapeutics, Inc. (Mirador), a clinical-stage precision medicine company developing next-generation therapies for immune-mediated inflammatory and fibrotic diseases, today announced key clinical updates and...

Converge Bio Raises $25M in Series A Funding

Artificial intelligence is moving quickly into drug discovery as pharmaceutical and biotech companies look for ways to cut years off R&D timelines and increase...

VieCure Raises $43M in Funding

VieCure, a leading provider of intelligent software platforms for oncology care, has raised $43 million in funding to accelerate its mission to democratize access to...

Orca Bio Raises $250M in Aggregate Funding

Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced the completion of a Series F...
- Advertisment -

Most Popular